CSPC Pharmaceutical Group Partners with China Unicom for Digital Transformation
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced a strategic partnership with Chinese mobile...
Deals
Neurophth Biotechnology Partners with Sinopharm Group to Commercialize Gene Therapy NFS-01
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced a strategic partnership with compatriot firm...
Innovent Biologics Partners with Merck KGaA to Test KRAS Inhibitor Combo in NSCLC
China-based Innovent Biologics (HKG: 1801) has announced a clinical study and supply agreement with German...
Shenzhen Abrobo Medical Robot Secures RMB 100 Million in Series A Financing for Robotic Development
Shenzhen Abrobo Medical Robot Co, Ltd has reportedly raised RMB 100 million via a Series...
Eikon Therapeutics Inks Licensing Deals and Raises Funds for Drug Pipeline Expansion
US biotech company Eikon Therapeutics has announced three in-licensing deals this week, one of which...
Sino Biopharmaceutical’s Subsidiary invoX Completes Additional Investment in pHion Therapeutics
The UK-based invoX Pharma Ltd, a wholly-owned subsidiary of China’s Sino Biopharmaceutical Ltd (HKG: 1177),...
Ucello Therapeutics Secures RMB 150 Million in Series A+ Financing for CAR-T Cell Therapy
Ucello Therapeutics, a developer of allogeneic universal chimeric antigen receptor (CAR)-T cell therapies based in...
Eversana Forms Strategic Alliance with China Resource Pharmaceutical for Healthcare Expansion
US-based commercial services provider Eversana has announced a strategic alliance with China Resource Pharmaceutical Commercial...
Adcendo ApS Expands Partnership with Duality Biologics for Two Additional ADCs
Denmark-based Adcendo ApS has announced the expansion and exercise of options to two additional antibody...
Amoytop Biotech and Fosun Pharmaceutical Ink Licensing Deal for Pegfilgrastim in China
Xiamen-based Amoytop Biotech Co. Ltd (SHA: 688278) has announced a licensing agreement with Shanghai Fosun...
Cutia Therapeutics Lists on HKEX with HKD527 Million IPO for Dermatology Therapies
Dermatology therapy developer Cutia Therapeutics (HKG: 2487) has successfully made its initial public offering (IPO),...
Betta Pharmaceuticals Secures Exclusive Rights to C4 Therapeutics’ CFT8919 in Greater China
China-based Betta Pharmaceuticals Co., Ltd (SHE: 300558) has announced an exclusive licensing agreement with US...
Lynk Pharmaceuticals Secures RMB 200 Million in Series C1 Financing Round
China-based Lynk Pharmaceuticals Co., Ltd has successfully raised RMB 200 million (USD 28.3 million) through...
XtalPi Partners with Eli Lilly for AI-Driven Drug Discovery Services
Sino-US artificial intelligence (AI) firm XtalPi Inc. has been enlisted by US-giant Eli Lilly &...
Galvanize Therapeutics Partners with Energenx Medical for Greater China Expansion
US-based Galvanize Therapeutics Inc. has revealed a licensing deal with Shanghai-based Energenx Medical Ltd, which...
Kangtai Biological Partners with Indian Pharmaceutical Giant for 13-Valent Pneumonia Vaccine
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601), a leading Chinese biopharmaceutical company, has entered...
Medtronic Launches AiBLE Orthopedic Ecosystem and Partners with Allinmd Orthopedics in China
US-based Medtronic Inc., (NYSE: MDT) has launched AiBLE, an innovative ecological ecosystem concept for orthopedics,...
TYK Medicines Partners with WuXi STA for Comprehensive CMC Services
Shanghai-based TYK Medicines has announced a partnership with WuXi STA, a subsidiary of WuXi AppTec...
Beijing’s E-Health Now Secures Tens of Millions in Series B Financing
E-Health Now, a comprehensive health management platform headquartered in Beijing, has reportedly raised tens of...
Boyi Biotech Secures Over RMB100 Million in Series A Financing Led by JOLMO
Boyi Biotech, a prominent biological microspheres developer headquartered in Changzhou, has reportedly secured more than...